Cover: The MAK Collection for Occupational Health and Safety

The MAK Collection for Occupational Health and Safety

German Research Foundation – Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area
(MAK Commission)

ISSN 2509-2383



Pentaborane

MAK Value Documentation, addendum – Translation of the German version from 2024

  Andrea Hartwig1 (Chair of the Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Deutsche Forschungsgemeinschaft)
  MAK Commission2

1 Institute of Applied Biosciences, Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology (KIT), Adenauerring 20a, Building 50.41, 76131 Karlsruhe, Germany
2 Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Deutsche Forschungsgemeinschaft, Kennedyallee 40, 53175 Bonn, Germany

Abstract

The German Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) re-evaluated the occupational exposure limit value (maximum concentration at the workplace, MAK value) for pentaborane [19624-22-7] considering all toxicological end points. Relevant studies were identified from a literature search. The critical effect of pentaborane is its effect on the central nervous system (CNS). Inadequately documented studies carried out before 1960 reported findings of CNS effects in humans at concentrations below 1 ml/m3 and in various animal species at the lowest concentration tested of 0.2 ml/m3 and above (exposure period: 6 months). In rats, guinea pigs, rabbits, dogs and monkeys, mortality was also observed at this concentration. As a result, no MAK value can be derived. Pentaborane, which is a liquid at room temperature, does not penetrate the skin in toxicologically relevant amounts. There are no studies investigating developmental toxicity, genotoxicity, carcinogenicity or the sensitizing potential of pentaborane.


Keywords

pentaborane, neurotoxicity, central nervous system, CNS